Fundamental dimension Equity attribute | AZTAPeer $36.50▲+1.36% Cap $1.60BP/E -13.3x QuantScore51/100 | BIOLeader $369.95▲+1.77% Cap $9.89BP/E 44.4x QuantScore53/100 | BLFSPeer $38.610.00% Cap $1.89BP/E 37.3x QuantScore51/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
71/100 |
84/100 |
74/100 |
Valuation Multiples, PEG & DCF upside | 25/100 | 40/100 | 16/100 |
Health Piotroski, Altman Z, leverage & liquidity | 71/100 | 70/100 | 80/100 |
Growth Revenue / earnings growth & margins | 37/100 | 35/100 | 62/100 |
Sentiment Analyst ratings, targets & revisions | 51/100 | 35/100 | 20/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -13.3x | 44.4x | 37.3x |
Forward P/E (next FY) | 114.8x | 37.9x | 64.4x |
EV / EBITDA (TTM) | -15.1x | 20.6x | 194.9x |
Price / Sales | 2.6x | 3.8x | 18.3x |
Price / Free Cash Flow | 161.8x | 28.0x | -2086.7x |
PEG ratio | 0.05 | -0.15 | -0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 7 / 9 | 5 / 9 |
Altman Z-Score | 3.87 (Safe) | 3.64 (Safe) | 40.85 (Safe) |
Total debt / equity | 0.04 | 0.17 | 0.04 |
Quick ratio | 2.2x | 2.3x | 7.1x |
Interest coverage | — | 6.4x | 11.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.6% | +0.7% | +17.0% |
Net income growth YoY | +66.2% | +141.2% | +39.9% |
Gross margin (TTM) | 44.0% | 51.9% | 64.5% |
Operating margin (FY) | -1.9% | 10.5% | -1.1% |
FCF margin (FY) | 6.5% | 14.5% | 0.4% |
5. Trailing price performancePrice change over period |
1M return | +6.7% | -4.5% | +0.1% |
3M return | +33.4% | +17.6% | +28.8% |
6M return | +40.9% | +28.5% | +80.6% |
Year to date | +9.7% | +22.1% | +59.7% |
1Y return | +13.1% | +8.9% | +34.1% |
3Y return | -27.7% | +21.8% | +291.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $10.55 -71.1% premium | $-169.71 -145.9% premium | $-1.67 -104.3% premium |
Wall Street consensus target | $43.00 +17.8% · range $38.00–$45.00 | $350.00 -5.4% · range $310.00–$390.00 | $31.00 -19.7% · range $31.00–$31.00 |
Consensus stance | 58% Buy42% Hold-0% Sell | 57% Buy43% Hold0% Sell | 67% Buy33% Hold0% Sell |